From 1976 to 1981, 11 patients underwent tricuspid valve replacement with bioprostheses.
All but one patient had either previous or concomitant left-sided valvular disease.
The mean preoperative functional class was 3.4. The operative mortality was 18% reflecting
the compromised preoperative cardiac state of most patients. There were neither early
nor late complications, and no deaths related to the tricuspid bioprosthesis after
a mean follow-up of 26 months. In particular, no signs of postoperative right heart
failure have been observed clinically.
Bioprosthesis - Tricuspid valve replacement
